p53, SKP2, and DKK3 as MYCN Target Genes and Their Potential Therapeutic Significance

by Chen, Lindi, Tweddle, Deborah A.
Published 2012

MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63

by Gamble, Laura D., Kees, Ursula R., Tweddle, Deborah A., Lunec, John
Published 2011

Temporal clustering of neuroblastic tumours in children and young adults from Northern England

by Muirhead, Colin R., Tweddle, Deborah A., Basta, Nermine O., McNally, Richard J. Q.
Published 2015

Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma

by Chen, Lindi, Rousseau, Raphaël F., Middleton, Steven A., Nichols, Gwen L., Newell, David R., Lunec, John, Tweddle, Deborah A.
Published 2015

Carboplatin therapeutic monitoring in preterm and full-term neonates

by Veal, Gareth J., Errington, Julie, Hayden, James, Hobin, David, Murphy, Dermot, Dommett, Rachel M., Tweddle, Deborah A., Jenkinson, Helen, Picton, Susan
Published 2015

Factors associated with recurrence and survival length following relapse in patients with neuroblastoma

by Basta, Nermine O, Halliday, Gail C, Makin, Guy, Birch, Jillian, Feltbower, Richard, Bown, Nick, Elliott, Martin, Moreno, Lucas, Barone, Giuseppe, Pearson, Andrew DJ, James, Peter W, Tweddle, Deborah A, McNally, Richard JQ
Published 2016

Methyl-CpG-binding domain sequencing reveals a prognostic methylation signature in neuroblastoma

by Decock, Anneleen, Ongenaert, Maté, Cannoodt, Robrecht, Verniers, Kimberly, De Wilde, Bram, Laureys, Geneviève, Van Roy, Nadine, Berbegall, Ana P., Bienertova-Vasku, Julie, Bown, Nick, Clément, Nathalie, Combaret, Valérie, Haber, Michelle, Hoyoux, Claire, Murray, Jayne, Noguera, Rosa, Pierron, Gaelle, Schleiermacher, Gudrun, Schulte, Johannes H., Stallings, Ray L., Tweddle, Deborah A., De Preter, Katleen, Speleman, Frank, Vandesompele, Jo
Published 2015